The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kutyrina I.M.

Otdel nefrologii NII uronefrologii i reproduktivnogo zdorov'ia cheloveka, kafedra nefrologii i gemodializa FPPOV Pervogo MGMU im. I.M. Sechenova Minzdrava Rossii

Rudenko T.E.

Otdel nefrologii NII uronefrologii i reproduktivnogo zdorov'ia cheloveka, kafedra nefrologii i gemodializa FPPOV Pervogo MGMU im. I.M. Sechenova Minzdrava Rossii

Saveleva S.A.

Endocrinology Research Centre, Moscow, Russian Federation

Shvetsov M.Yu.

Kafedra nefrologii i gemodializa FPPOV Pervogo MGMU im. I.M. Sechenova Minzdrava Rossii

Vasil'eva M.P.

Otdel nefrologii NII uronefrologii i reproduktivnogo zdorov'ia cheloveka, kafedra nefrologii i gemodializa FPPOV Pervogo MGMU im. I.M. Sechenova Minzdrava Rossii

Risk factors for cardiovascular system damage in chronic kidney disease

Authors:

Kutyrina I.M., Rudenko T.E., Saveleva S.A., Shvetsov M.Yu., Vasil'eva M.P.

More about the authors

Journal: Therapeutic Archive. 2013;85(9): 69‑76

Read: 2656 times


To cite this article:

Kutyrina IM, Rudenko TE, Saveleva SA, Shvetsov MYu, Vasil'eva MP. Risk factors for cardiovascular system damage in chronic kidney disease. Therapeutic Archive. 2013;85(9):69‑76. (In Russ.)

Recommended articles:
Epidemiology and prevention of prostate cancer. Russian Journal of Preventive Medi­cine. 2025;(7):111-118
Chro­nic kidney disease and microcirculation diso­rders. Russian Journal of Preventive Medi­cine. 2025;(8):123-130
Cere­bral venous thro­mbosis in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):11-19
Sex and age characteristics of stroke risk factors in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):89-97
Economics of hype­rparathyroidism. Part 2 — seco­ndary hype­rparathyroidism. Medi­cal Technologies. Asse­ssment and Choice. 2025;(3):74-82

References:

  1. Schiffrin E.L., Lipman M., Mann J.F.E. Chronic kidney disease. Effects on the cardiorenal system. Circulation 2007; 116: 85-97.
  2. Ronco C., Haapio M., House A. et al. Cardiorenal syndrome. JACC 2008; 52 (19); 1527-1539.
  3. Mukhin N.A., Moiseev V.S. Kardiorenal'nye sootnosheniya i risk serdechno-sosudistykh zabolevanii. Vestn RAMN 2003; 11: 50-55.
  4. Wright J., Hutchison A. Cardiovascular disease in patients with chronic kidney disease. Vascular Health Risk Management 2009; 5: 713-722.
  5. de Lusignan S., Chan T., Stevens P. et al. Identifying patients with chronic kidney disease from general practice computer records. Fam Pract 2005; 22 (3): 234-241.
  6. Smirnov A.V., Dobronravov V.A., Rumyantsev A.Sh., Mnuskina M.M. Faktory riska IBS u bol'nykh, poluchayushchikh lechenie gemodializom. Nefrologiya 2002; Prilozhenie 1: 7-13.
  7. Tonelli M., Bohm C., Pandeya S. et al. Cardiac risk factors and use of cardioprotective medication in predialysis patients. J Am Soc Nephrol 2000; 11: 169 A (abstr).
  8. Cheung A., Sarnak M., Yan G. et al. Atherosclerotic cardiovascular disease in chronic hemodialysis patients. Kidney Int 2000; 58: 353-362.
  9. Glassok RJ., Pecoita-Filho R., Barberato S.H. Left ventricular mass in chronic kidney disease and ESRD. CJASN 2009; 4: S79-91.
  10. Smirnov A.V., Dobronravov V.A., Kayukov I.G. Kardiorenal'nyi kontinuum: patogeneticheskie osnovy preventivnoi nefrologii. Nefrologiya 2005; 3: 7-15.
  11. Ninomiya T., Kiyohara Y., Kubo M. et al. Chronic renal disease in a general Japanese population: The Hisayama Study. Kidney Int 2005; 68: 228-236.
  12. van Kuijk J-P., Flu W-J., Chonchol M. et al. Prevalence and prognostic implications of polyvascular atherosclerotic disease in patients with chronic kidney disease. Nephrol Dial Transplant 2010; 25: 1882-1888.
  13. Yildiz A., Memisoglu E., Oflaz H. et al. Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic hemodialysis patients. Nephrol Dial Transplant 2005; 20: 760-767.
  14. Schwartz U., Buzello M., Ritz E. et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 2000; 15: 218-223.
  15. Briet M., Boutouyrie P., Laurent S., London G. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int 2012; 68 (82): 388-400.
  16. Laurnet S., Boutouyrie P., Asmar R. et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
  17. London G.M., Marchais S.J., Guerin A.P. et al. Arterial structure and function in end - stage renal disease. Nephrol Dial Transplant 2002; 17: 1713-1724.
  18. Szczech LA., Best PJ, Crowley E. et al. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Outcomes of patients with chronic renal insufficiency in the Bypass Angioplasty Revascularization Investigation. Circulation 2002; 105: 2253-2258.
  19. Salmasi A., Jepson E., Grenfell A. et al. The degree of albuminuria is related to left ventricular hypertrophy in hypertensive diabetics and is associated with abnormal left ventricular filling: a pilot study. Angiology 2003; 54 (6): 671-678.
  20. Palmieri M., Tracy R., Roman M. et al. Relation of Left Ventricular Hypertrophy to Inflammation and Albuminuria in Adults With Type 2 Diabetes. The Strong Heart Study. Diabetes Care 2003; 26 (10): 2764-2769.
  21. Cheng S., Xanthakis V., Sullivan L. et al. Correlates of Echocardiographic Indices of Cardiac Remodeling Over the Adult Life Course: Longitudinal Observations From the Framingham Heart Study. Circulation 2010; 122 (6): 570-578.
  22. Lauer M., Anderson K., Kannel W., Levy D. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 1991; 266: 231-236.
  23. Schirmer H., Lunde P., Rasmussen K. Prevalence of left ventricular hypertrophy in a general population; The Tromso Study. Eur Heart J 1999; 20 (6): 429-438.
  24. Jain A., Avendano G., Dharamsey S. Dasmahaparta A. et al. Left ventricular diastolic function in hypertension and role of plasma glucose and insulin: comparison with diabetic heart. Circulation 1996; 93: 1396-1402.
  25. Dedov I.I., Shestakova M.V. Sakharnyi diabet i arterial'naya gipertenziya. M: Meditsinskoe informatsionnoe agentstvo 2006; 341.
  26. Donskov A.S., Balkarov I.M., Golub' G.V. i dr. Svyaz' mezhdu massoi miokarda levogo zheludochka i narusheniem obmena mochevoi kisloty u bol'nykh arterial'noi gipertoniei. Ter arkh 2001; 6: 31-33.
  27. Kuo C., Yu K., Luo S. et al. Role of uric acid in the link between arterial stiffness and cardiac hypertrophy: a cross-sectional study. Rheumatology 2010; 49 (6): 1189-1196.
  28. Johnson R. The planetary biology of ascorbate and uric acid and their relationship with epidemic of obesity and cardiovascular disease. Med Hypotheses 2008; 71 (1): 22-31.
  29. Mukhin N.A., Fomin V.V., Lebedeva M.V. Giperurikemiya kak komponent kardiorenal'nogo sindroma. Ter arkh 2011; 6: 5-9.
  30. Majane O., Vengethasamy L., Toit E. et al. Dietary-induced obesity hastens the progression from concentric cardiac hypertrophy to pump dysfunction in spontaneously hypertensive rats. Hypertension 2009; 54 (6): 1376-1383.
  31. Rajapurohitam V., Gan X., Kirshenbaum L., Karmazyn M. The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circul Res 2003; 93: 277.
  32. Mitsuhashi H., Yatsuya H., Tamakoshi K. et al. Adiponectin level and left ventricular hypertrophy in Japanese men. Hypertension 2007; 49: 1448.
  33. Gustafsson S., Lind L., Zethelius B. et al. Adiponectin and cardiac geometry and function in elderly: results from two community-based cohort studies. Eur J Endocrinol 2010; 162 (3): 543-550.
  34. Kozakova M., Muscelli E., Flyvbjerg A. et al. Adiponectin and Left Ventricular Structure and Function in Healthy Adults. J Clin Endocrinol Metab 2008; 93 (7): 2811-2818.
  35. Eynatten M., Liu D., Hock C. et al. Urinary Adiponectin Excretion A Novel Marker for Vascular Damage in Type 2 Diabetes. Diabetes 2009; 58 (9): 2093-2099.
  36. Shestakova M.V., Dedov I.I. Sakharnyi diabet i khronicheskaya bolezn' pochek. M: Meditsinskoe informatsionnoe agentstvo 2009; 482.
  37. Shestakova M.V., Yarek-Martynova I.R., Ivanishina N.S. Kardiorenal'naya patologiya pri sakharnom diabete 1-go tipa: mekhanizmy razvitiya i vozmozhnosti medikamentoznoi korrektsii. Ter arkh 2005; 6: 40-46.
  38. Shestakova M.V., Yarek-Martynova I.V., Ivanishina I.S. Kardiorenal'nyi sindrom pri sakharnom diabete 1-go tipa: rol' disfunktsii endoteliya. Kardiologiya 2005; 6: 35-41.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.